Enables protein-macromolecule adaptor activity. Involved in retrograde transport, vesicle recycling within Golgi. Located in Golgi membrane. Orthologous to human CUX1 (cut like homeobox 1); INTERACTS WITH 6-propyl-2-thiouracil; acrylamide; ammonium chloride.
[Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of CUX1 mRNA and [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CUX1 mRNA
[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CUX1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CUX1 mRNA
[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CUX1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CUX1 mRNA
MT1 affects the reaction [Copper results in increased expression of CUX1 mRNA] and MT2 affects the reaction [Copper results in increased expression of CUX1 mRNA]
MT1 affects the reaction [Copper results in increased expression of CUX1 mRNA] and MT2 affects the reaction [Copper results in increased expression of CUX1 mRNA]
[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CUX1 mRNA
[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CUX1 mRNA
[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CUX1 mRNA